H.U. Group Holdings, Inc. (TYO:4544)
Japan · Delayed Price · Currency is JPY 3,594.00
+58.00 (1.64%)
Aug 12, 2026, 1:30 PM JST
H.U. Group Holdings Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 247,362 | 247,362 | 243,025 | 236,950 | 260,908 | 272,944 |
Revenue Growth | 1.79% | 1.79% | 2.56% | -9.18% | -4.41% | 22.39% |
Gross Profit Gross Profit Growth | 71,385 | 71,385 | 67,198 | 63,235 | 89,924 | 111,799 |
Operating Income Operating Income Growth | 4,780 | 4,780 | 2,346 | -4,044 | 23,381 | 50,491 |
Net Income Net Income Growth | 6,823 | 6,823 | 2,761 | -7,553 | 15,676 | 29,599 |
Earnings Per Share EPS Growth | 121.42 | 121.42 | 48.59 | -132.77 | 275.50 | 519.42 |
EPS Growth | 149.87% | 149.87% | - | - | -46.96% | 69.57% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Clinical Test Drugs Business Clinical Test Drugs Business Growth | 64,990 | 64,990 | 64,971 | 67,515 | 77,666 | 74,171 |
Healthcare Related Service Healthcare Related Service Growth | 29,452 | 29,452 | 29,565 | 28,317 | 27,772 | 28,698 |
Unallocated Adjustment Unallocated Adjustment Growth | -4,686 | -4,686 | -4,996 | -5,871 | -7,917 | -10,165 |
Inspection and Related Service Inspection and Related Service Growth | 157,605 | 157,605 | 153,485 | 146,988 | 163,387 | 180,239 |
Total Total Growth | 247,361 | 247,361 | 243,025 | 236,949 | 260,908 | 272,943 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 48,105 | 48,105 | 40,885 | 39,947 | 44,186 | 46,490 |
Total Debt Total Debt Growth | 74,330 | 74,330 | 86,652 | 81,945 | 77,164 | 72,999 |
Net Cash (Debt) Net Cash Growth | -26,225 | -26,225 | -45,767 | -41,998 | -32,978 | -26,509 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -466.65 | -466.65 | -805.50 | -738.28 | -579.56 | -465.19 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 21,565 | 21,565 | 21,964 | 16,551 | 32,535 | 55,229 |
Capital Expenditures CapEx Growth | -2,355 | -2,355 | -4,083 | -12,370 | -14,232 | -23,733 |
Free Cash Flow Free Cash Flow Growth | 19,210 | 19,210 | 17,881 | 4,181 | 18,303 | 31,496 |
Free Cash Flow Growth | 7.43% | 7.43% | 327.67% | -77.16% | -41.89% | 30.92% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 28.86% | 28.86% | 27.65% | 26.69% | 34.47% | 40.96% |
Operating Margin | 1.93% | 1.93% | 0.97% | -1.71% | 8.96% | 18.50% |
Pretax Margin | 3.47% | 3.47% | 1.32% | -3.22% | 8.78% | 15.14% |
Profit Margin | 2.76% | 2.76% | 1.14% | -3.19% | 6.01% | 10.84% |
FCF Margin | 7.77% | 7.77% | 7.36% | 1.76% | 7.02% | 11.54% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 125.000 | 125.000 | 125.000 | 125.000 | 125.000 | 125.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 3.54% | 3.92% | 4.73% | 5.56% | 5.34% | 5.14% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 29.12 | 25.95 | 56.48 | - | 9.68 | 5.58 |
Forward PE | 35.43 | 31.22 | 28.57 | 29.81 | 13.71 | 10.97 |
P/FCF Ratio | 10.12 | 9.22 | 8.72 | 33.20 | 8.29 | 5.25 |
PS Ratio | 0.79 | 0.72 | 0.64 | 0.59 | 0.58 | 0.61 |